Session Details

[P2-05]Poster Session 2-05 Complex Disorders

Fri. Dec 19, 2025 5:50 PM - 6:50 PM JST
Fri. Dec 19, 2025 8:50 AM - 9:50 AM UTC
Poster Room 1 (301+302, 3F, PACIFICO Yokohama)

[P2-05-1]Association analysis of the moyamoya disease susceptibility gene RNF213 in cervical internal carotid artery stenosis

Yui Mitani1, Kenko Azuma1, Hideaki Onda2, Hidenori Ohbuchi3, Yuichi Kubota3, Takakazu Kawamata4, Hiroyuki Akagawa1,3 (1.Institute for Comprehensive Medical Sciences, Tokyo Womenʼs Medical University, Tokyo, Japan, 2.Kofu Neurosurgical Hospital, 3.Department of Neurosurgery, Tokyo Womenʼs Medical University Adachi Medical Center, 4.Department of Neurosurgery, Tokyo Womenʼs Medical University)

[P2-05-2]Association of FAM13A variant with interstitial lung disease in ANCA-associated vasculitis in a Japanese population

Yuka Kawamura1, Ken-Ei Sada2,3, Kenji Itoh4, Nobuyuki Ono5, Tomoaki Higuchi6, Shigeto Kobayashi7, Kenji Nagasaka8, Takahiko Sugihara9, Takashi Fujimoto10, Makio Kusaoi11, Takashi Higuchi12, Kunihiro Yamagata13, Takayuki Sumida14, Hiroshi Hashimoto15, Hirofumi Makino16, Yoshihiro Arimura17,18, Masayoshi Harigai6, Naoto Tamura11, Naoyuki Tsuchiya1, Aya Kawasaki1 (1.Molecular and Genetic Epidemiology, University of Tsukuba, Tsukuba, Japan, 2.Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Graduate School of Medicine, Okayama, Japan, 3.Department of Clinical Epidemiology, Kochi University, Kochi, Japan, 4.Division of Hematology and Rheumatology, National Defense Medical College, Tokorozawa, Japan, 5.Department of Rheumatology, Faculty of Medicine, Saga University, Saga, Japan, 6.Division of Rheumatology, Department of Internal Medicine, Tokyo Womenʼs Medical University, Tokyo, Japan, 7.Department of Internal Medicine, Juntendo University Koshigaya Hospital, Koshigaya, Japan, 8.Department of Rheumatology, Ome Medical Center, Ome, Japan, 9.Division of Rheumatology, Department of Internal Medicine, Toho University School of Medicine, Tokyo, Japan, 10.Department of General Medicine, Nara Medical University, Nara, Japan, 11.Department of Internal Medicine and Rheumatology, Juntendo University Faculty of Medicine, Tokyo, Japan, 12.Department of Nephrology, Ushiku Aiwa General Hospital, Ushiku, Japan, 13.Department of Nephrology, University of Tsukuba, Tsukuba, Japan, 14.Department of Internal Medicine, University of Tsukuba, Tsukuba, Japan, 15.School of Medicine, Juntendo University, Tokyo, Japan, 16.Okayama University, Okayama, Japan, 17.Department of Nephrology and Rheumatology, Kyorin University, Tokyo, Japan, 18.Department of Internal Medicine, Kichijoji Asahi Hospital, Tokyo, Japan)

[P2-05-3]Genetic risks of common side effects following COVID-19 booster vaccination in a cohort of corporate employees in Japan

Yosuke Omae1,2, Seik-Soon Khor1, Mihoko Shimada1, Yosuke Kawai1, Taihei Yamaguchi2, Maiko Yagi2, Masashi Ebisawa2, Junko Takeuchi3, Tetsuya Mizoue3, Wataru Sugiura3, Katsushi Tokunaga1 (1.Genome Medical Science Project, National Institute of Global Health and Medicine, Japan Institute for Health Security, 2.Life Science Business Office, Corporate Technology Planning Division, Toshiba Corporation, Tokyo, Japan, 3.Center for Clinical Sciences, Japan Institute for Health Security, Tokyo, Japan)

[P2-05-4]Abnormal feeding and anxiety-like behaviors are induced in female mice by a CRHR2 variant

Akira Oka1, Ayaka Nakamura2, Hiromi Miura1, Masato Ohtsuka1 (1.Department of Molecular Life Sciences, Division of Basic Medical Science and Molecular Medicine, Tokai University School of Medicine, 2.The Support Center for Medical Research and Education, Tokai University)

[P2-05-5]An early neonatal death case of X-linked myotubular myopathy successfully diagnosed after birth by exome sequencing

Akinori Nukariya1, Yuki Ito1, Yuto Turuoka1, Takeshi Nagao2, Tokumasa Suemitu1, Taisuke Sato1, Erina Nagao3, Masahisa Kobayashi3, Kana Harada4, Chisen Takeuchi4, Hiromi Kamura2, Ryo Kikuchi5,6, Kenji Kobayashi5, Hitoshi Matui1, Taizan Kamide1, Kosuke Taniguchi7, Kenichiro Hata7, Masayuki Shimoda5, Osamu Samura1, Aikou Okamoto1 (1.Department of Obstetrics and Gynecology, The Jikei University School of Medicine, 2.Department of Maternal-Fetal Biology, National Research Institute for Child Health and Development, 3.Department of Pediatrics, The Jikei University School of Medicine, 4.Department of Clinical Genetics, The Jikei University Hospital, 5.Department of Pathology, The Jikei University School of Medicine, 6.Toda Central Pathology Institute, 7.Department of Human Molecular Genetics, Gunma University Graduate School of Medicine)

[P2-05-6]Effect of CXCR5-positive B cells on disease susceptibility and activity in primary biliary cholangitis (PBC)

Yuki Hitomi1,2, Yoshihiro Aiba3, Kazuko Ueno2, Haruka Takahashi4,5, Michihiro Kono4,5, Nao Nishida6, Yosuke Kawai2, Minae Kawashima7, Seik-Soon Khor2,2,8, Michio Yasunami9, Kazuyoshi Ishigaki4,5, Masao Nagasaki10,11, Katsushi Tokunaga2, Minoru Nakamura3,10,12 (1.Institute of Biomedical Sciences, Fukushima Medical University School of Medicine, 2.National Institute of Global Health and Medicine, Japan Institute for Health Security, 3.Clinical Research Center, NHO Nagasaki Medical Center, 4.RIKEN Center for Integrative Medical Sciences, 5.Keio University School of Medicine, 6.Medical Research Laboratory, Institute of Science Tokyo, 7.Database Center for Life Science, Research Organization of Information and Systems, 8.Singapore Centre for Environmental Life Sciences Engineering, Nanyang Technological University, 9.Medical Research Institute, Saga-Ken Medical Centre Koseikan, 10.Medical Institute of Bioregulation, Kyushu University, 11.Graduate School of Medicine, Kyoto University, 12.Nagasaki University Graduate School of Biomedical Sciences)